Journals / İstanbul Kuzey Klinikleri / 2019 / Cilt: 6 - Sayı: 1

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator

Pages
40–47
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Accordingly, MADIT-ICD scores (1.29 [1.00–1.68], p=0.050), hemoglobin (0.86 [0.75–0.99],p=0.047), and left ventricular ejection fraction (EF) (0.97 [0.94–0.99], p=0.023) were determined as independent predictorsof major adverse cardiovascular events in the long-term follow-up of ICD-implanted population.CONCLUSION: In this study, we showed that there was an independent association of long-term adverse cardiovascularevents with MADIT-ICD score, hemoglobin, and EF in patients implanted with ICD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: To test the hypothesis that multicenter automatic defibrillator implantation trial (MADIT) - implantable cardioverter-defibrillator (ICD) scores predict replacement requirement and appropriate shock in a mixed population includingboth primary and secondary prevention and long-term adverse cardiovascular events.METHODS: The study has a retrospective design.
📊
Key Findings & Data:Patients who were implanted with ICD in the cardiology clinic of AtatürkUniversity Faculty of Medicine between 2000 and 2013 were included in the study.
💡
Conclusion & Impact:Accordingly, MADIT-ICD scores (1.29 [1.00–1.68], p=0.050), hemoglobin (0.86 [0.75–0.99],p=0.047), and left ventricular ejection fraction (EF) (0.97 [0.94–0.99], p=0.023) were determined as independent predictorsof major adverse cardiovascular events in the long-term follow-up of ICD-implanted population.CONCLUSION: In this study, we showed that there was an independent association of long-term adverse cardiovascularevents with MADIT-ICD score, hemoglobin, and EF in patients implanted with ICD.
🔬Design:Review & Systematic Survey
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: To test the hypothesis that multicenter automatic defibrillator implantation trial (MADIT) - implantable cardioverter-defibrillator (ICD) scores predict replacement requirement and appropriate shock in a mixed population includingboth primary and secondary prevention and long-term adverse cardiovascular events.METHODS: The study has a retrospective design. Patients who were implanted with ICD in the cardiology clinic of AtatürkUniversity Faculty of Medicine between 2000 and 2013 were included in the study. For this purpose, 1394 patients who wereimplanted with a device in our clinic were reviewed. Then, those who were implanted with permanent pacemaker (n=1005),cardiac resynchronization treatment (CRT) (n=45) and CRT-ICD (n=198) were excluded.RESULTS: A total of 146 patients (98 males, 67.1%) with a mean age of 61.1 (±14.8) years were recruited. The medianfollow-up time was 21.5 months (mean 30.6±25.9 months; minimum 4 months, and maximum 120 months). The medianMADIT-ICD scores in the patients were 2. MADIT-ICD scores were categorized as low in 15.1%, intermediate in 57.5%, andhigh score in 27.4% of patients. Accordingly, MADIT-ICD scores (1.29 [1.00–1.68], p=0.050), hemoglobin (0.86 [0.75–0.99],p=0.047), and left ventricular ejection fraction (EF) (0.97 [0.94–0.99], p=0.023) were determined as independent predictorsof major adverse cardiovascular events in the long-term follow-up of ICD-implanted population.CONCLUSION: In this study, we showed that there was an independent association of long-term adverse cardiovascularevents with MADIT-ICD score, hemoglobin, and EF in patients implanted with ICD.

🔖

Cite This Article

DUMAN, H., SEVİMLİ, S., TANBOGA, I. H., DOGAN, C., AŞKIN, L., USLU, A. (2022). Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator. İstanbul Kuzey Klinikleri, Cilt: 6 - Sayı: 1, 40–47. https://ajindex.com/articles/551494

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs implantable defibrillator study. Cardiac arrest study hamburg. Canadian implantable defibrillator study. Eur Heart J 2000
  2. 2071–8. [CrossRef ] 2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002
  3. 877– 83. [CrossRef ] 3. Barsheshet A, Moss AJ, Huang DT, McNitt S, Zareba W, Goldenberg I, et al. Applicability of a risk score for prediction of the long-term (8- year) benefit of the implantable cardioverter-defibrillator. J Am Coll Cardiol 2012
  4. 2075–9. [CrossRef ] 4. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008
  5. 288–96. [CrossRef ] 5. Braunwald E, Zipes DP, Libby P, Bonow RO. Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. Philedelphia, PA: Saunders Elsevier
  6. p. 933–74. 6. Spooner PM, Albert C, Benjamin EJ, Boineau R, Elston RC, George AL Jr., et al. Sudden cardiac death, genes, and arrhythmogenesis: Consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I. Circulation 2001
  7. 2361–4. [CrossRef ] 7. Cummins RO, Ornato JP, Thies WH, Pepe PE. Improving survival from sudden cardiac arrest: The “chain of survival” concept. A statement for health professionals from the advanced cardiac life support subcommittee and the emergency cardiac care committee, American heart association. Circulation 1991
  8. 1832–47. [CrossRef ] 8. Bayés de Luna A, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989
  9. 151–9. [CrossRef ] 9. Buxton AE, Fisher JD, Josephson ME, Lee KL, Pryor DB, Prystowsky EN, et al. Prevention of sudden death in patients with coronary artery disease: The multicenter unsustained tachycardia trial (MUSTT). Prog Cardiovasc Dis 1993
  10. 215–26. [CrossRef ] 10. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular